#DaiichiSankyo

Announces a correction to a part of the FY2025 financial summary. Recognized an additional liability of 31.6 billion yen directly related to assets held for sale, related to current liabilities.

Daiichi Sankyo has revised its consolidated earnings forecast for the fiscal year ending March 2026 due to a review of its product supply plan, expecting losses. Revenue has been revised downward to approximately ¥21.23 trillion, and operating profit to approximately ¥2.29 billion.

For FY2025, net sales are revised to JPY 2,123 billion (up JPY 23 billion from the previous forecast), core operating profit is revised to JPY 360 billion (+JPY 10 billion), and operating profit is revised to JPY 229 billion (down JPY 106 billion).

Daiichi Sankyo Company, Limited has postponed the fiscal year ending March 2026 earnings announcement from April 27, 2026 to May 11, 2026, and plans to announce the 6th Mid-term Management Plan on the same day.

All shares of Daiichi Sankyo Healthcare are transferred to Suntory Holdings for a total of 246.5 billion yen. The transfer will be implemented in phases starting June 2026 and completed by June 2029.

From March 1 to March 24, 2026, 13,854,700 shares of treasury stock were acquired for approximately 39,997,547,100 yen, completing the acquisition based on the Board of Directors resolution on April 25, 2025.

From February 1 to February 28, 2026, the Company acquired 14,198,900 shares of common stock for ¥41,849,992,950. The total cumulative shares acquired amount to 17,602,500 shares, with an acquisition cost of ¥51,849,239,900.

Change of representative director effective June 22, 2026. Mr. Takashi Matsumoto is scheduled to assume the new representative director role. Selection of director and auditor candidates has also been conducted to enhance diversity and expertise.

From January 1 to January 31, 2026, Daiichi Sankyo Company, Limited acquired 3,403,600 shares of the Company’s common stock at a total cost of 9,999,246,950 yen.

For the third quarter of the fiscal year ending March 2026, revenue amounted to JPY 1,533.5 billion (12.1% YoY increase), core operating income was JPY 249.2 billion (8.8% YoY increase), operating income was JPY 233.8 billion (5.9% YoY decrease), and net income attributable to owners of the parent for the quarter was JPY 217.4 billion (4.2% YoY increase).

For the cumulative third quarter of FY2025, revenue was 1,533.5 billion yen (YoY +12.1%), operating income was 233.8 billion yen (YoY -5.9%), and net income attributable to owners of parent was 217.4 billion yen (YoY +4.2%).

For the cumulative third quarter of fiscal 2025, revenue was JPY 1,533.5 billion (YoY +12.1%), core operating income was JPY 249.2 billion (YoY +8.8%), and net income attributable to owners of parent was JPY 217.4 billion (YoY +4.2%), reflecting profit growth.